Where does Haemonetics Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Haemonetics Corporation ranks #5,592 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Haemonetics Corporation hold?

Haemonetics Corporation holds 61 US utility patents granted between 2015 and 2025, spanning 22 technology areas.

What is Haemonetics Corporation's Innovation Score?

Haemonetics Corporation has an Innovation Score of 52.1 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Haemonetics Corporation's patent grant rate increasing or decreasing?

Haemonetics Corporation's recent grant velocity is +59% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Haemonetics Corporation's patents?

Haemonetics Corporation's patents average 23.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Haemonetics Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Haemonetics Corporation

Q: What technology areas does Haemonetics Corporation focus on?

Haemonetics Corporation's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 37 patents, ranking #198 of 3,490 assignees active in that subclass. Grants appear in 22 CPC subclasses total.

USPTO PatentsView assignee record - 61 granted patents across 22 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Haemonetics ranks #5,592 of 49,997 tracked US assignees by granted-patent volume, with 61 patents across 22 technology areas.

#5,592
of 49,997 US assignees by volume: Top 11%
by Innovation Score (52.1/100): 23.8
avg claims per patent: +59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5592 · US Corporation #5,592 · 61 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 61 grants
UPPER-Q #5,592/49,997
PHOTO-FINISH Gen Digital
CPC-FOCUS A61M · 22 areas
INNOV-PAR 52.1/100
CLAIMS-DENSE 23.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gen Digital Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Haemonetics’s 52.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.3 pts (27%) Velocity 7.0 pts (13%) Breadth 16.6 pts (32%) Claim depth 14.3 pts (27%)

Qualcomm Incorporated · highest

85
Berry Plastics · near

52
Digital Seat Media · near

52
Haemonetics · this assignee

52
Koninklijke Philips · near

52
Matrixed Reality… · near

52
3D Lighting… · lowest

7

What this shows Haemonetics's Innovation Score is 52.1/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Haemonetics?

Each dot is one of Haemonetics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Haemonetics’s own 23.8 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Haemonetics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Haemonetics's grants concentrate

Haemonetics Corporation is a focused PatentsView assignee: 22 CPC subclasses with 60.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (11 grants) versus a trough of 2 in 2018. By volume, Haemonetics sits between Groz-beckert KG and Inpria Corporation.

Haemonetics's three-year grant acceleration

Haemonetics Corporation shows 20 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Groz-beckert KG

61
Gen Digital

61
Hydac Filtertechn…

61
Hydro-quÉBEC

61
Harbin Engineerin…

61
Infinidat

61
Innovaplant Zierp…

61
Inpria

61
Haemonetics ◀

61

What this shows Haemonetics holds 61 patents at rank #5,593, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Haemonetics

By rank, the assignees closest to #5,593 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Haemonetics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Haemonetics, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Haemonetics ranks #198 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Koninklijke Philips Electronics NV 52 Berry Plastics Corporation 52 Matrixed Reality Technology Co., Ltd. 52 Digital Seat Media, Inc. 52

Similar claim depth

Nearest assignees by average claims per patent (23.8 here).

Hollingsworth & Vose Company 23.8 avg Koninklijke Douwe Egberts B.V. 23.8 avg Array BioPharma, Inc. 23.8 avg Instart Logic, Inc. 23.7 avg

Haemonetics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Haemonetics Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	4.9%
2016	8	13.1%
2017	5	8.2%
2018	2	3.3%
2019	4	6.6%
2020	7	11.5%
2021	8	13.1%
2022	2	3.3%
2023	11	18.0%
2024	7	11.5%
2025partial year	4	6.6%

Which technologies does Haemonetics Corporation patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 37

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 24

B04B - Centrifuges 11

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 7

B01D - Separation 7

A61B - DIAGNOSIS; SURGERY; Identification 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 4

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 3

F16M - Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports 3

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 2

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 1

G02B - Optical Elements, Systems OR Apparatus 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

Top 15 of 22 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Haemonetics Corporation's patent record in context - here's where to go next.

Haemonetics Corporation's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 60.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #5,592 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Haemonetics Corporation against Groz-beckert KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.